Authority: National Company Law Appellate Tribunal Principal Bench, New Delhi
Order Date: 09 July 2026
Case Overview
The National Company Law Appellate Tribunal (NCLAT) heard Comp. App. (AT) (Ins) No. 391 of 2025, an appeal filed by Mahima Lifesciences Pvt. Ltd. against Ajay Kumar Agarwal, the Interim Resolution Professional (IRP) of Concept Biosciences India Pvt. Ltd., and another respondent. The hearing, conducted in hybrid mode, was primarily procedural to address the representation of a newly impleaded party, Respondent No.2.
Ms. Urvija Shamra, appearing through video conference, informed the bench that she would be representing the newly impleaded Respondent No.2. She further submitted that the steps ordered by the tribunal on 21 May 2026 to serve the newly impleaded respondent had not been completed. Additionally, a copy of the interlocutory application (I.A. No. 6115 of 2025 in CA(AT)(Ins.) No. 391 of 2025) had not been provided to her.
Final Outcome
The two-member bench, comprising Justice Mohammad Faiz Alam Khan (Member-Judicial) and Naresh Salecha (Member-Technical), issued procedural directions. The bench directed the learned counsel for the appellant (Mahima Lifesciences) to provide a copy of the Memorandum of Appeal along with a copy of I.A. No. 6115 of 2025 to Ms. Urvija Shamra on her email address on the same day (09 July 2026). The newly impleaded Respondent No.2 was granted two weeks to file a reply, with an advance copy to be provided to the appellant's counsel. The appellant was given one week thereafter to file a rejoinder, if any. The substantive hearing of the appeal was adjourned and listed for the next hearing on 03 August 2026.
Topics: NCLAT Procedure, Corporate Insolvency, Legal Adjournment